Companies: 10,795·Total market cap: $144.5T
Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc.

KYMRNASDAQHealthcare● Active
$74.40
+$0.27(+0.36%)
Market Cap$6.1B
P/E Ratio
52W High$103
52W Low$36.65
Overview

Kymera Therapeutics, Inc. (KYMR) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · KYMR · as of Feb 26, 2026

Latest filing snapshot

238
+50+26.60%vs prior year

Kymera Therapeutics, Inc. (KYMR) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
238
Change (1Y)
+50
Growth % (1Y)
+26.60%
Revenue / Employee
$164.7K
Net Income / Employee
$-1.31M
Market Cap
$6.1B

KYMR Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-26238+50+26.60%
2025-02-27188+1+0.53%
2024-02-22187+20+11.98%
2023-02-23167+26+18.44%
2022-02-24141+66+88.00%
2021-03-1175

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
ACADIA Pharmaceuticals Inc.
ACAD
ACADIA Pharmaceuticals Inc.
653
#2
Ascentage Pharma Group International
AAPG
Ascentage Pharma Group International
567
#3
Crinetics Pharmaceuticals, Inc.
CRNX
Crinetics Pharmaceuticals, Inc.
437
#4
Immunovant, Inc.
IMVT
Immunovant, Inc.
362
#5
Kymera Therapeutics, Inc.
KYMR
Kymera Therapeutics, Inc.YOU
238
#6
Arcellx, Inc.
ACLX
Arcellx, Inc.
163
#7
Akero Therapeutics, Inc.
AKRO
Akero Therapeutics, Inc.
69
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · KYMR peer comparison

About KYMR employees

KYMR Employees · Headcount

Kymera Therapeutics, Inc. (KYMR) employee data is sourced from the annual SEC 10-K filing. As of 2025, Kymera Therapeutics, Inc. had 238 full-time employees globally. Full-time employees only. Global consolidated headcount.

Kymera Therapeutics, Inc. employs 238 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $164,706, reflecting the company's operational efficiency.

Kymera Therapeutics, Inc.'s workforce increased by 50 (26.60%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Kymera Therapeutics, Inc.'s revenue per employee of $164,706 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

KYMR Employees · 5 questions

As of the latest SEC 10-K filing (2025), Kymera Therapeutics, Inc. had 238 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Kymera Therapeutics, Inc. employee counthow many employees does Kymera Therapeutics, Inc. haveKYMR total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26